Author： Papaetis Georgios S. Syrigos Kostas N.
Publisher： Adis International
ISSN： 1173-8804
Source： BioDrugs, Vol.23, Iss.6, 2009-12, pp. : 377-389
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Receptor Kinase Inhibitors Target NSCLC†: Two Antibodies and a Small-Molecule MET Inhibitor
By Yee David
BioDrugs, Vol. 25, Iss. 4, 2011-08 ,pp. :
Access to resources
Recommend
Molecular Therapies for Viral Hepatitis
By Guha C. Shah S.J. Ghosh S.S. Lee S.W. Roy-Chowdhury N. Roy-Chowdhury J.
BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. :
By Ciavarella Sabino Milano Annalisa Dammacco Franco Silvestris Franco
BioDrugs, Vol. 24, Iss. 2, 2010-04 ,pp. :
Advances in Chemotherapy and Targeted Systemic Therapies for Urothelial Cancer
Current Drug Therapy, Vol. 5, Iss. 1, 2010-02 ,pp. :
Cyclin-Dependent Kinase Modulators and Cancer Therapy
By Gallorini Marialucia Cataldi Amelia >
BioDrugs, Vol. 26, Iss. 6, 2012-12 ,pp. :